We are solving the greatest challenges in venous access.


Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access. Our first product, FDA-cleared HydroPICC, has demonstrated a 30x reduction in thrombosis versus a standard polyurethane catheter.*

*Data on file at Access Vascular. Reduction of thrombosis accumulation was evaluated using in vitro and in vivo models.



Our hydrogel biomaterial is designed to reduce thrombosis, a leading cause of multiple complications for indwelling catheters.

Blood Flow Loop Results.png

FDA-Cleared HydroPICC

Could HydroPICC improve your patients’ outcomes? Learn about adding HydroPICC to your practice.


PowerPICC and BioFlo are registered trademarks of Bard Access Systems and AngioDynamics, respectively.